Pravin S. Bhale

Pravin S. Bhale

Auto-generated profile, based on publicly available information

Pravin S. Bhale

Yeshwantrao Chavan Mahavidyalaya, Tuljapur-413601, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
PBPravin S. Bhale
Pravin S. Bhale
HCHemant V. Chavan
Hemant V. Chavan
SDSakharam B. Dongare
Sakharam B. Dongare
SSSadanand N. Shringare
Sadanand N. Shringare
YMYoginath B. Mule
Yoginath B. Mule
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar

1 March 2013 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
HCHemant V. Chavan
Hemant V. Chavan
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar
LALaxman K. Adsul
Laxman K. Adsul
VDValmik D. Dhakane
Valmik D. Dhakane
PBPravin S. Bhale
Pravin S. Bhale
VMVijay Hariram Masand
Vijay Hariram Masand

7 February 2018 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
SSSadanand N. Shringare
Sadanand N. Shringare
HCHemant V. Chavan
Hemant V. Chavan
PBPravin S. Bhale
Pravin S. Bhale
SDSakharam B. Dongare
Sakharam B. Dongare
YMYoginath B. Mule
Yoginath B. Mule
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar

1 January 2016 in Chinese Chemical Letters
Verified
Journal Article
Closed access
SDSakharam B. Dongare
Sakharam B. Dongare
HCHemant V. Chavan
Hemant V. Chavan
PBPravin S. Bhale
Pravin S. Bhale
YMYoginath B. Mule
Yoginath B. Mule
AKAmol S. Kotmale
Amol S. Kotmale
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar

25 January 2019 in Phosphorus, Sulfur, and Silicon and the Related Elements
Verified
Journal Article
Closed access
PBPravin S. Bhale
Pravin S. Bhale
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar
SDSakharam B. Dongare
Sakharam B. Dongare
SSSadanand N. Shringare
Sadanand N. Shringare
DSDnyaneshwar M. Sirsat
Dnyaneshwar M. Sirsat
HCHemant V. Chavan
Hemant V. Chavan

10 July 2018 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
PBPravin S. Bhale
Pravin S. Bhale
HCHemant V. Chavan
Hemant V. Chavan
SDSakharam B. Dongare
Sakharam B. Dongare
SSSadanand N. Shringare
Sadanand N. Shringare
YMYoginath B. Mule
Yoginath B. Mule
BBBabasaheb P. Bandgar
Babasaheb P. Bandgar
Background: Breast cancer is the most common invasive cancer in female worldwide. Indole scaffold represents an important class of therapeutic agents in medicinal chemistry. Many indole derivatives are reported as potent anticancer agents. This study aims to design, and synthesize anti-breast cancer potential of new bisindole derivatives. Method: The target molecules were prepared by reacting cyano acetyl indoles with substituted indole-3- carboxyaldehydes in the presence of piperidine. All the newly synthesized compounds were in vitro screened for their anticancer activities against breast carcinoma (MCF-7) by employing the sulforhodamine B (SRB) assay method. Results: Preliminary in vitro evaluation indicated that most of the compounds possess distinct cytotoxicity profile against MCF-7 cell line compared to standard drug adriamycin. Among them, compounds 5g, 5b, and 5q demonstrated excellent activities against breast carcinoma (GI50 < 0.1µM) as good as adriamycin (GI50 < 0.1µM). Active compounds were further subjected for molecular docking and bioavailability studies. These studies supported activities of the present series compounds. Conclusion: New anti-breast cancer agents are the need of time, we believe that the new α-cyano substituted 1,3-bisindolyl-2-propen-1-one derivative 5g reported in this work may provide an interesting insight for further optimization.